Search research articles
Contact Us
Filters
Showing results (11-20 of 23) with videos related to
Page
of 3
Sort By:
NPJ Precision Oncology
|
February 25, 2026
Personalized signaling pathway analysis of gastrointestinal tumors for patient stratification and drug target evaluation using clinically derived core biopsies
Aaron Stahl, Karsten Büringer, Pavlos Missios, et al.
Clinical Nuclear Medicine
|
January 25, 2024
Radiosensitizing Favors Response to Peptide Receptor Radionuclide Therapy in Patients With Highly Proliferative Neuroendocrine Malignancies: Preliminary Evidence From a Clinical Pilot Study
Nils Florian Trautwein, Clemens Hinterleitner, Lena Sophie Kiefer, et al.
Journal for Immunotherapy of Cancer
|
October 9, 2025
Exceptional tumor-free survival of a patient with metastatic intrahepatic cholangiocarcinoma after surgery and personalized peptide vaccination: revisiting a striking case
Ana Maia, Juliane Schuhmacher, Silvio Nadalin, et al.
Journal of Medical Internet Research
|
July 18, 2025
Streamlining a Patchwork - Exploring the Challenges of Digital Transformation in Pathology: Ethnographic Study
Birte Linny Geisler, Ourania Amperidou, Sina Patricia Pauly, et al.
Cancers
|
November 27, 2025
Results of the First Folate Receptor Alpha Testing Trial by the German Quality Assurance Initiative in Pathology (QuIP<sup>®</sup>)
Alexander Scheiter, Sven Mattern, Verena Gassenmaier, et al.
Frontiers in Oncology
|
March 18, 2021
Case Report: Combined CDK4/6 and MEK Inhibition in Refractory CDKN2A and NRAS Mutant Melanoma
Andrea Forschner, Tobias Sinnberg, Gabi Mroz, et al.
EMBO Molecular Medicine
|
February 3, 2025
An AI-assisted morphoproteomic approach is a supportive tool in esophagitis-related precision medicine
Sven Mattern, Vanessa Hollfoth, Eyyub Bag, et al.
NPJ Precision Oncology
|
September 4, 2021
Targeting extracellular and juxtamembrane FGFR2 mutations in chemotherapy-refractory cholangiocarcinoma
Michael Bitzer, Stephan Spahn, Sepideh Babaei, et al.
Nature Communications
|
December 2, 2021
Platelet PD-L1 reflects collective intratumoral PD-L1 expression and predicts immunotherapy response in non-small cell lung cancer
Clemens Hinterleitner, Jasmin Strähle, Elke Malenke, et al.
Molecular & Cellular Proteomics : MCP
|
July 23, 2025
Accurate MS-Based Diagnostic Amyloid Typing Using Endogenously Normalized Protein Intensities in Formalin-Fixed Paraffin-Embedded Tissue
Vanessa Hollfoth, Arslan Ali, Eyyub Bag, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 23) with videos related to
Sort By:
Page
of 3
NPJ Precision Oncology
|
February 25, 2026
Personalized signaling pathway analysis of gastrointestinal tumors for patient stratification and drug target evaluation using clinically derived core biopsies
Aaron Stahl, Karsten Büringer, Pavlos Missios, et al.
Clinical Nuclear Medicine
|
January 25, 2024
Radiosensitizing Favors Response to Peptide Receptor Radionuclide Therapy in Patients With Highly Proliferative Neuroendocrine Malignancies: Preliminary Evidence From a Clinical Pilot Study
Nils Florian Trautwein, Clemens Hinterleitner, Lena Sophie Kiefer, et al.
Journal for Immunotherapy of Cancer
|
October 9, 2025
Exceptional tumor-free survival of a patient with metastatic intrahepatic cholangiocarcinoma after surgery and personalized peptide vaccination: revisiting a striking case
Ana Maia, Juliane Schuhmacher, Silvio Nadalin, et al.
Journal of Medical Internet Research
|
July 18, 2025
Streamlining a Patchwork - Exploring the Challenges of Digital Transformation in Pathology: Ethnographic Study
Birte Linny Geisler, Ourania Amperidou, Sina Patricia Pauly, et al.
Cancers
|
November 27, 2025
Results of the First Folate Receptor Alpha Testing Trial by the German Quality Assurance Initiative in Pathology (QuIP<sup>®</sup>)
Alexander Scheiter, Sven Mattern, Verena Gassenmaier, et al.
Frontiers in Oncology
|
March 18, 2021
Case Report: Combined CDK4/6 and MEK Inhibition in Refractory CDKN2A and NRAS Mutant Melanoma
Andrea Forschner, Tobias Sinnberg, Gabi Mroz, et al.
EMBO Molecular Medicine
|
February 3, 2025
An AI-assisted morphoproteomic approach is a supportive tool in esophagitis-related precision medicine
Sven Mattern, Vanessa Hollfoth, Eyyub Bag, et al.
NPJ Precision Oncology
|
September 4, 2021
Targeting extracellular and juxtamembrane FGFR2 mutations in chemotherapy-refractory cholangiocarcinoma
Michael Bitzer, Stephan Spahn, Sepideh Babaei, et al.
Nature Communications
|
December 2, 2021
Platelet PD-L1 reflects collective intratumoral PD-L1 expression and predicts immunotherapy response in non-small cell lung cancer
Clemens Hinterleitner, Jasmin Strähle, Elke Malenke, et al.
Molecular & Cellular Proteomics : MCP
|
July 23, 2025
Accurate MS-Based Diagnostic Amyloid Typing Using Endogenously Normalized Protein Intensities in Formalin-Fixed Paraffin-Embedded Tissue
Vanessa Hollfoth, Arslan Ali, Eyyub Bag, et al.
Page
of 3